We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-49.00 | -3.24% | 1,465.00 | 1,461.00 | 1,466.00 | 1,468.00 | 1,365.00 | 1,453.00 | 129,196 | 10:34:31 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 989.86 | 1.98B |
TIDMINDV
RNS Number : 4750F
Indivior PLC
17 May 2017
Indivior PLC (the 'Company')
Poll results of 3(rd) Annual General Meeting ('AGM')
May 17, 2017
The Company announces that at its AGM, held on May 17, 2017, all resolutions set out in the Notice of AGM were passed on a poll.
Resolutions 1 to 17 were passed as Ordinary Resolutions and Resolutions 18 to 21 were passed as Special Resolutions. The following table sets out the votes cast on each resolution:
RESOLUTION VOTES % VOTES % VOTES % of VOTES FOR AGAINST TOTAL ISC WITHHELD VOTED ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 1. To receive the Company's accounts, the strategic report and reports of the Directors and the Auditor for the year ended December 31, 2016. 524,593,969 100.00 15,100 0.00 524,609,069 72.76 2,249,385 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 2. To approve the Directors' Remuneration Report for the year ended December 31, 2016. 491,470,055 93.29 35,357,161 6.71 526,827,216 73.07 38,905 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 3. To re-appoint Howard Pien as a Director. 494,499,743 94.18 30,581,956 5.82 525,081,699 72.83 1,777,552 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 4. To re-appoint Shaun Thaxter as a Director. 526,781,490 99.99 32,605 0.01 526,814,095 73.07 45,057 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 5. To re-appoint Mark Crossley as a Director. 526,793,635 100.00 20,125 0.00 526,813,760 73.07 45,391 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 6. To re-appoint Yvonne Greenstreet as a Director. 392,217,897 75.47 127,514,829 24.53 519,732,726 72.09 7,126,426 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 7. To re-appoint A. Thomas McLellan as a Director. 367,951,220 70.80 151,784,716 29.20 519,735,936 72.09 7,123,216 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 8. To re-appoint Tatjana May as a Director. 526,778,462 99.99 35,744 0.01 526,814,206 73.07 44,946 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 9. To re-appoint Lorna Parker as a Director. 526,716,359 99.98 101,025 0.02 526,817,384 73.07 41,768 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 10. To re-appoint Daniel J. Phelan as a Director. 522,856,902 99.25 3,959,688 0.75 526,816,590 73.07 42,562 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 11. To re-appoint Christian Schade as a Director. 526,439,271 99.93 376,961 0.07 526,816,232 73.07 42,920 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 12. To re-appoint Daniel Tassé as a Director. 526,785,878 100.00 25,002 0.00 526,810,880 73.07 48,272 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 13. To re-appoint Lizabeth Zlatkus as a Director. 526,770,965 99.99 43,365 0.01 526,814,330 73.07 44,822 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 14. To re-appoint PricewaterhouseCoopers LLP as Auditors of the Company. 520,059,460 98.72 6,767,691 1.28 526,827,151 73.07 32,000 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 15. To authorize the Audit Committee of the Board to determine the remuneration of the Auditors. 524,649,612 99.59 2,201,640 0.42 526,851,252 73.07 7,600 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 16. To authorize the Company and any of its UK subsidiaries to make political donations and incur political expenditure. 520,738,886 98.85 6,063,612 1.15 526,802,498 73.07 46,645 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 17. That the Directors be generally and unconditionally authorized to allot shares in the Company up to an aggregate nominal amount of US$48,051,850. 521,220,993 98.94 5,599,906 1.06 526,820,899 73.07 38,253 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 18. That the Directors be authorized to disapply pre-emption rights up to 5% of the issued capital. 526,674,569 99.97 135,576 0.03 526,810,145 73.07 49,006 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 19. That the Directors be authorized to disapply pre-emption rights up to an additional 5% for transactions which the Board determines to be an acquisition or other capital investment. 520,497,517 98.80 6,318,185 1.20 526,815,702 73.07 43,448 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 20. That the Company be generally and unconditionally authorized to make market purchases of its own ordinary shares. 518,740,916 98.77 6,471,697 1.23 525,212,613 72.85 1,646,538 ------------------------ ----------- ------ ----------- ----- ----------- ------ --------- 21. That a general meeting other than an annual general meeting may be called on 14 clear days' notice. 511,083,505 97.07 15,449,689 2.93 526,533,194 73.03 324,693 ------------------------ ----------- ------ ----------- ----- ----------- ------ ---------
At the Annual General Meeting of Indivior PLC held earlier today, votes of 24.53% and 29.20% were recorded against resolutions 6 and 7 to re-appoint Yvonne Greenstreet and A. Thomas McLellan as Directors of the Company. The Board, after discussion, believes it is likely that the level of votes cast against these resolutions was due to the absence of these two directors from certain Board and Committee meetings in 2016.
Tom McLellan did not attend two scheduled Board meetings during the year. One of these absences in May 2016 was as a result of him attending a meeting of cabinet and legislators in the US focused exclusively on opioid issues. Tom McLellan did not attend the Board Meeting in November 2016 as he was attending the US Government's publication of the Surgeon General's Report on Alcohol, Drugs and Health. Both absences were discussed by the Board in advance and it was agreed that it was in the best interests of Indivior, of patients and of wider stakeholders that he attend these meetings.
Tom McLellan is an expert in the field of addiction and at the centre of his work is the health and welfare of patients. He is a very strong contributor on all areas of Board discussion and his expertise is invaluable.
Ad-hoc Board Meetings, by their very nature, are often called at short notice and it is not always possible for Directors to attend, given other scheduled commitments. For this reason, both Tom McLellan and Yvonne Greenstreet were unable to attend a number of such meetings at different times during 2016.
We confirm that Yvonne Greenstreet and Tom McLellan have attended every Board meeting in the current year and have no planned absences.
A copy of the special business resolutions will be submitted to the National Storage Mechanism and will be available to view at http://www.morningstar.co.uk/uk/NSM in due course.
As at the close of business on May 16, 2017, the total number of ordinary shares of US$0.10 each eligible to be voted at the AGM was 720,988,383. Therefore, the total voting rights in the Company as at that time were 720,988,383.
Computershare Investor Services PLC acted as scrutineer of the poll on all resolutions.
Contact: Kathryn Hudson
Company Secretary
Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGQDLFFDEFXBBE
(END) Dow Jones Newswires
May 17, 2017 12:36 ET (16:36 GMT)
1 Year Indivior Chart |
1 Month Indivior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions